Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Individualized therapies for non-Hodgkin's lymphoma identified with PET

Individualized therapies for non-Hodgkin's lymphoma identified with PET

Peregrine Pharmaceuticals awarded two new U.S. patents for targeted anti-aminophospholipid agents

Peregrine Pharmaceuticals awarded two new U.S. patents for targeted anti-aminophospholipid agents

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

ThromboGenics and BioInvent report positive results for anti-PlGF cancer therapeutic TB-403

ThromboGenics and BioInvent report positive results for anti-PlGF cancer therapeutic TB-403

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

Peregrine Pharmaceuticals updates on Bavituximab breast cancer study

First patient enrolled in phase III study of Bevacizumab and Trastuzumab in early breast cancer

First patient enrolled in phase III study of Bevacizumab and Trastuzumab in early breast cancer

Discovery provides hope for patients with pancreatic cancer

Discovery provides hope for patients with pancreatic cancer

Discovery of quick method for making human monoclonal antibodies against flu

Discovery of quick method for making human monoclonal antibodies against flu

Quantum rods light up pancreatic cancer cells

Quantum rods light up pancreatic cancer cells

Drugs in the pipeline: new therapies that could change treatment strategies

Drugs in the pipeline: new therapies that could change treatment strategies

Scientists create monoclonal antibody libraries against avian influenza

Scientists create monoclonal antibody libraries against avian influenza

Targeted therapy combo overcomes treatment resistance in liver cancer

Targeted therapy combo overcomes treatment resistance in liver cancer

Targeted therapies overcome treatment resistance in liver cancer cell lines

Targeted therapies overcome treatment resistance in liver cancer cell lines

Wistar Institute shares cell lines

Wistar Institute shares cell lines

PharmAthene signs agreement to acquire biodefense vaccines business from Avecia

PharmAthene signs agreement to acquire biodefense vaccines business from Avecia

MedImmune advances clinical development of antibody targeting interleukin-9 in patients with asthma

MedImmune advances clinical development of antibody targeting interleukin-9 in patients with asthma

Modified virus vaccine shows promise in mouse model of breast cancer

Modified virus vaccine shows promise in mouse model of breast cancer

Cancer drug allergies

Cancer drug allergies

Researchers find cause of severe allergic reaction to cetuximab

Researchers find cause of severe allergic reaction to cetuximab

Home test kit confirms men's post-vasectomy sterility

Home test kit confirms men's post-vasectomy sterility

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.